SAN DIEGO, CA, June 30, 2022 (World NEWSWIRE) — via NewMediaWire — Health care Cannabis, Inc. (OTC: MJNA) (the “Company”), the 1st-at any time publicly traded hashish company in the United States that released the world’s very first-ever hashish-derived nutraceutical merchandise, manufacturers, and offer chain, announced nowadays that its subsidiary Kannaway® will be web hosting its South Africa Regional Meeting in Cape Town this Saturday, July 2, 2022.
“Kannaway has experienced an extraordinary begin in South Africa and our upcoming in the region is pretty dazzling,” mentioned Medical Cannabis, Inc. CEO Blake Schroeder. “South Africa’s CBD industry is projected to be a $7 billion sector by 2023. We intend to be the driving drive all over awareness, schooling, and hashish-based possibility to capture a significant share of the marketplace.”
This celebration, which will consider spot at the Cape Town Global Conference Centre, is designed to serve as a premier networking opportunity for business owners to master how they can get associated in South Africa’s emerging hashish field. It will also characteristic several seasoned hemp industry industry experts together with Founder Dr. Stuart Titus, CEO Blake Schroeder, Kannaway South Africa State Supervisor, Dudu Mathole, and Kannaway’s first South African Intercontinental Director, Adriaan Pieterse. The party will present facts about CBD and its advantages, Kannaway’s line of items in South Africa, and entrepreneurial possibility within the firm.
“It has been an incredible practical experience working with Kannaway and I search ahead to talking with present and likely business people at the party about how I have observed accomplishment with the corporation and how they can too,” mentioned Adriaan Pieterse. “Kannaway is major the CBD market place in South Africa and it is an honor to enable drive its mission to boost the wellness of individuals all-around the world.”
About Health care Cannabis, Inc.
We are a organization of firsts®. Professional medical Marijuana, Inc. (MJNA) is a hashish corporation with 3 unique company models in the non-psychoactive cannabinoid room: a world portfolio of cannabinoid-based mostly nutraceutical manufacturers led by Kannaway® and HempMeds® a pioneer in sourcing the maximum-high-quality authorized non-psychoactive hashish merchandise derived from industrial hemp and a cannabinoid-based mostly clinical investigation and botanical drug progress sector led by its pharmaceutical expense corporations and companions like AXIM® Biotechnologies, Inc.and Neuropathix. Clinical Cannabis, Inc. was named a leading CBD producer by CNBC. Healthcare Marijuana, Inc. was also the initial organization to obtain historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the advancement of international marketplaces. The firm’s flagship product Real Scientific Hemp Oil has been employed in various effective medical reports all through Mexico and Brazil to comprehend its security and efficacy.
Healthcare Marijuana, Inc.’s headquarters is in San Diego, California, and supplemental facts is obtainable at OTCMarkets.com or by traveling towww.medicalmarijuanainc.com. To see Healthcare Cannabis, Inc.’s company movie, click on in this article.
Forward-Seeking DISCLAIMER
This press launch may perhaps consist of specified forward-hunting statements and information and facts, as outlined inside the that means of Section 27A of the Securities Act of 1933 and Portion 21E of the Securities Trade Act of 1934, and is issue to the Secure Harbor produced by those people sections. This content contains statements about expected long run events and/or economical final results that are forward-hunting in character and issue to threats and uncertainties. Such ahead-seeking statements by definition contain threats, uncertainties and other aspects, which could trigger the actual outcomes, performance or achievements of Professional medical Cannabis, Inc. to be materially various from the statements built herein.
Food stuff AND DRUG ADMINISTRATION (Food and drug administration) DISCLOSURE
These statements have not been evaluated by the Food items and Drug Administration. This solution is not supposed to diagnose, treat, get rid of, or protect against any disorder.
Authorized DISCLOSURE
Health care Cannabis, Inc. does not promote or distribute any solutions that are in violation of the United States Controlled Substances Act.
Contact:
General public Relations Get in touch with:
Kathryn Brown
Account Director
CMW Media
P. 858-221-8001
kathryn@cmwmedia.com
www.cmwmedia.com
Trader Relations Call:
P. (858) 283-4016
Buyers@medicalmarijuanainc.com
